glp-1 pancreatic cancer The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and | Cancer and Metastasis Reviews Favorable Effects of GLP-1 Receptor

(2025, November 13)

These findings provide compelling evidence in support of the hypothesis that GLP-1 RAs inhibit glucagon secretion by stimulating the release of somatostatin, an effect that is independent of insulin and the secretory products of -cells

These require immediate medical attention if they occur

Biochem J 361(3):417429 Wasserman K, Whipp BJ (1975) Exercise physiology in health and disease

Bellia F, Calabrese V, Guarino F, Cavallaro M, Cornelius C, De Pinto V, Rizzarelli E

Ongoing research and clinical trials will continue to inform their safety profile, ensuring that healthcare providers can make informed decisions